Concepedia

Jeffrey L. Klaus

JL

7

Publications

1.1K

Citations

7

H-Index

1995

Active since

Affiliations

Sunesis (United States)(Current)

Abbott (United Kingdom)

Abbott Fund

Jeffrey L. Klaus is an author at Sunesis (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1995–2003

7

Publications

7

Vinyl Sulfones as Mechanism-Based Cysteine Protease Inhibitors

James T. Palmer, David Rasnick, Jeffrey L. Klaus et al. · Journal of Medicinal Chemistry · 1995 · 504 citations · Full text

, , +17

Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors

Philip J. Rosenthal, Jed Olson, G K Lee et al. · Antimicrobial Agents and Chemotherapy · 1996 · 187 citations · Full text

, , +12

Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L

Dieter Brömme, Jeffrey L. Klaus, Kathleen Okamoto et al. · Biochemical Journal · 1996 · 139 citations · Full text

Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex

Christopher J. Linnevers, Mary E. McGrath, Andy Armstrong et al. · Protein Science · 1997 · 108 citations · Full text

Fluorescent microplate assay for cancer cell‐associated cathepsin B

Keren I. Hulkower, Christopher Butler, Bruce E. Linebaugh et al. · European Journal of Biochemistry · 2000 · 66 citations · Full text

Rows per page

1–5 of 7